PRO-122

· Laboratorios Sophia S.A de C.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PRO-122, covering 2019-12-13 to 2025-03-06. Get the full timeline:

Most recent: Clinical Trial Update: PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM) [Phase 3]

See pricing